Supplement

See all supplements

Leukaemia

Vol. 498 No. 7389_supp ppS1-S42
  • In this Supplement

  • While survival rates for some types of leukaemia have improved dramatically, this family of blood cancers remains a potentially fatal disease. Research in epigenetics, immunotherapy, and cell transplants offers hope. And leukaemia is proving a testing ground for the theory of cancer stem cells — leading to knowledge that could advance cancer research overall.

    Cover Art: Nik Spencer

Outlook

Top

Video

Top
  • When blood goes bad

    How to view this content

    You will need javascript enabled and the Flash browser plugin to access this movie.

    Unfortunately we are unable to provide accessible alternatives for this content. If you need help accessing the content in this movie, please email npg@nature.com.

    Originally thought to be an infection, leukaemia is the malignant malfunction in the production of blood cells. Nature Video looks inside the broken machinery to see what goes awry in the main forms of this cancer – a disease that is becoming less lethal thanks to the development of precisely targeted drugs.

Collection

Top

Sponsor:

Novartis Oncology Baxter International Onconova Therapeutics